He then adds that for older individuals, treatment may involve isometric knee exercises without the need for ACL reconstruction. “The MCL, located on the outside of the knee joint, can suffer ...

Compelling clinical results for GLPG5101 in three NHL indications underscore potential of innovative decentralized cell therapy platform to ...

Compelling clinical results for GLPG5101 in three NHL indications underscore potential of innovative decentralized cell therapy platform to deliver fresh, fit cells, in median seven days vein-to-vein ...

The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo), for the treatment ... cell lymphoma (MCL) ineligible for autologous ...

Behind-the-knee pain could be due to muscle strain or arthritis—or something far more serious. Orthopedic experts say these ...

After suffering an MCL injury during the Lions’ Week 15 loss to the Buffalo Bills, Montgomery was initially feared to be done for the season. However, the veteran back opted for rehab over ...

A championship lost and a year-after collapse. A bye week declaration. A torn knee and a Black Panther. A book, an OC and so ...

Montgomery suffered an MCL injury. His season was thought to be ... That was the plan of attack when he began his rehab. He conducted strenuous, targeted exercises, all in an effort to get back ...

Dr. Tycel Phillips discusses the implications of the FDA approval of Calquence plus bendamustine and Rituxan in untreated MCL ...

Calquence, a BTK inhibitor, is now approved for first-line treatment of MCL, offering a new therapeutic option for patients ineligible for stem cell transplantation. The ECHO trial showed significant ...

Feb. 5. 2025 – The FDA has approved a new pill to treat adults with a type of blood cancer called mantle cell lymphoma (MCL). This treatment is for people who are newly diagnosed or haven't h ...